All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2020-002011-21||Bicentric, phase 2, randomized, open-label study to evaluate the efficacy and safety of maraviroc associated with standard treatment in hospitalized patients with pulmonary SARS-CoV-2 infection (COVID...||not-yet-due|
|Ongoing, reported early||2020-004279-42||Standard vs High PROphylactic doses or anticoagulation in patients with high risk of THROMbosis admitted with COVID-19 pneumonia Ensayo Clínico que evalúa la tromboprofilaxis óptima y las estrategi...||not-yet-due|
|Ongoing||2021-001028-16||DEXamethasone EARLY administration in hospitalized patients with Covid-19 pneumonia and high risk of developing acute respiratory distress syndrome Administración precoz de dexametasona en paciente...||not-yet-due|
|Ongoing||2021-001416-29||EARLY TREATMENT STRATEGY WITH HIGH-DOSE VERSUS STANDARD-DOSE DEXAMETHASONE IN PATIENTS WITH SARS-COV-2 PNEUMONIA (COVID-19). ESTRATEGIA DE TRATAMIENTO PRECOZ CON DEXAMETASONA A DOSIS ALTAS FRENTE ...||not-yet-due|